Improving IBD outcomes through community awareness, referrals, and education
Official title: RFA-DP-23-002, Improving Health Outcomes for Patients with Inflammatory Bowel Disease through Evidence-based Awareness, Referral, and Education Programs
Funded at Crohn's and Colitis Fdn of America, INC. · NIH-11403048 · Data updated 2026-11-12
A U01 grant will support programs to raise awareness, improve referrals, and educate patients and clinicians about inflammatory bowel disease to improve diagnosis and care.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Crohn's and Colitis Fdn of America, INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 30, 2023 |
| Project end | September 29, 2028 |
| Funding year | 2026 |
| Award (this year) | $737,000 |
| NIH project number | 5U01DP006746-04 |
| Project ID | NIH-11403048 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with Crohn's disease or ulcerative colitis, including pediatric patients and diverse racial/ethnic groups, who may benefit from improved awareness and faster referrals.
✕Less likely to help
Patients in areas without access to the targeted education and referral programs may see little direct benefit.
What this research studies
This funding supports efforts to reduce delays in diagnosing Crohn's disease and ulcerative colitis and to address disparities in care among diverse populations. By combining education for patients and families with outreach to healthcare providers, the project aims to streamline referral pathways and ensure timely, effective treatment. The approach will consider social determinants of health to tailor strategies for different communities and ages, including children with pediatric-onset IBD. Outcomes will be tracked to see if awareness and education translate into faster diagnosis, better disease management, and fewer complications.
Why it matters
Potential benefit: If successful, patients with IBD may receive quicker diagnoses and more appropriate, timely treatment, leading to better quality of life.
How similar studies have gone: Previous studies show that targeted education and streamlined referrals can reduce delays and improve care in chronic diseases, though results for IBD may vary by population.
Where this research is happening
-
Crohn's and Colitis Fdn of America, INC.
New York, United States Active
Researchers
- Principal investigator: Wingate, Laura Dawn — Crohn's and Colitis Fdn of America, INC.
- Study coordinator: Wingate, Laura Dawn
Related research
Other NIH-funded projects on the same topics.
-
Mitochondrial Talks: How Energy Networks Shape Inflammatory Bowel Disease
Aimed at people with inflammatory bowel disease (IBD), this project explores how tiny cell powerhouses in the gut may go out of balance and contribute to IBD, with the goal of restoring energy and reducing disease symptoms.
-
Mn in inflammatory bowel disease: how manganese and genes may shape gut inflammation
This grant studies how the mineral manganese and a specific gene variant may influence inflammatory bowel disease in people of different ages.
-
AI-Enhanced Virtual Reality CBT to Reduce Anxiety for IBD Patients
A home-based VR and AI-powered cognitive behavioral therapy program is being tested to help people with inflammatory bowel disease feel less anxious and improve their quality of life.
-
Gasdermin-based epithelial function in inflammatory bowel disease
A funding opportunity that explores how gasdermin proteins affect the lining of the gut and may influence inflammatory bowel disease.
-
Intestinal chondroitin sulfate glycosaminoglycans and their role in inflammatory bowel disease
A clinician-scientist mentoring program aims to advance understanding of how intestinal sugar molecules called chondroitin sulfate glycosaminoglycans influence inflammatory bowel disease and patient care.
-
Engineered gut-targeted regulatory T cells for inflammatory bowel disease
A new allogeneic, gut-focused cell therapy using engineered regulatory T cells to help people with inflammatory bowel disease feel better and stay in remission.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.